22 May 2013
Keywords: eli, lilly, raloxifene, phase, ii, results, reported
Article | 26 April 1993
Eli Lilly has reported Phase II trial results of its selective
anti-estrogen drug, raloxifene, at last month's International Symposium
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 April 1993
19 April 1993
21 May 2013
© 2013 thepharmaletter.com